Trilaktan

Ophthalmology

Indications for use

Reduction of elevated intraocular pressure in adults and children (over the age of 1 year) with open-angle glaucoma or increased ophthalmotonus.

Therapeutic class:

Antiglaucoma agent – Synthetic analog of prostaglandin F2α

INN

Latanoprost

Market authorization in the following countries

Belarus

Cambodia

Back to catalog